The Balancing Act: Managing Blood Pressure and Gravity
At a Glance
Managing blood pressure in idiopathic peripheral autonomic neuropathy means preventing dangerous drops when you stand without causing high pressure when you lie down. Individualized fluids, salt, positioning, compression, medication timing, and monitoring help maintain this balance safely.
Managing blood pressure in Idiopathic Peripheral Autonomic Neuropathy (IPAN) and Pure Autonomic Failure (PAF) is a delicate balancing act. The goal is rarely to reach a “normal” blood pressure of 120/80. Instead, your care team focuses on a “functional” blood pressure: high enough to keep you from fainting when you stand, but not so high that it damages your organs while you sleep [1][2].
This balance involves managing two opposite problems: neurogenic orthostatic hypotension (nOH) (dangerously low pressure when upright) and supine hypertension (dangerously high pressure when lying flat) [3][4].
The Non-Drug Foundation
Before starting medications, several daily habits and physical tools are used to support your blood pressure. These are often the most important parts of your treatment plan [5][6].
1. Hydration and Salt
Your clinician may direct an individualized trial of increased salt and fluid intake [7]. A “water bolus”—drinking about 16 ounces of cold water quickly—can raise your blood pressure by 30 to 40 mmHg for an hour or two, providing a temporary “safety window” for activity [8].
- Important Safety Warning: Increasing salt (which is different from sodium) and fluid is not safe for everyone. It must be individualized and monitored by your clinician, especially if you have uncontrolled hypertension, edema (swelling), heart failure, kidney disease, or liver disease. Your doctor will monitor your weight, electrolytes, and blood pressure to ensure this doesn’t worsen supine hypertension or fluid overload.
2. Physical Tools
- Sit or Lie Down Immediately: If you feel lightheaded, faint, or presyncopal, sit or lie down immediately.
- Counter-Maneuvers: Only when it is safe to do so, you can use physical tricks to squeeze blood back toward your heart. These include crossing your legs while standing, tensing your leg and glute muscles, or leaning forward [9][10].
- Abdominal Binders: Compressing the belly is more effective than compression stockings alone. It prevents blood from “pooling” in the large veins of your abdomen [6][11]. A binder can improve standing systolic blood pressure by about 10 mmHg [11].
- Head-of-Bed Elevation: You should never sleep flat. Elevating the entire head of your bed by 6 to 12 inches (20–30 cm) is a primary treatment for high nighttime blood pressure [12][13]. This helps your kidneys process fluid properly and prevents you from being “dehydrated” by morning [4][14].
- Daily Life Advice: Avoid prolonged standing, excess heat, and large amounts of alcohol. Perform recumbent or seated exercise (like recumbent biking or swimming), and always rise from a sitting or lying position in slow, deliberate stages.
Medication Options
If non-drug measures aren’t enough, your doctor may prescribe “pressor” medications to raise your blood pressure. These are usually timed to be active only when you are upright [15].
| Medication | Typical Dosing Examples | How it Works |
|---|---|---|
| Midodrine | 2.5–10 mg, 3 times daily [15] | Directly tightens the blood vessels to raise pressure [16]. |
| Droxidopa | 100–600 mg, 3 times daily [17] | A “pro-drug” that your body converts into norepinephrine [18]. |
- These doses are examples only; do not start, stop, or change medications without your prescriber. Both can worsen supine hypertension.
- Timing: These are typically taken first thing in the morning, at midday, and in the late afternoon. Doses are commonly individualized to be taken at least 3 to 4 hours before bedtime. If you unexpectedly need to lie down for a nap or procedure during the day, discuss adjusting your dose with your doctor [15][3].
- Side Effects: Midodrine can cause “goosebumps,” scalp itching, or worsen urinary retention [16]. Droxidopa may cause headaches or nausea, and carries cardiac/arrhythmia concerns [19][18].
The Risks of Fludrocortisone
While Fludrocortisone is an older medication often used for low blood pressure, it is used with extra caution in IPAN and PAF [6][3]. Unlike the drugs above, it works by making your kidneys hold onto salt and water to expand your blood volume [20].
Caution is required because Fludrocortisone requires monitoring of potassium, kidney function, fluid retention, and blood pressure. It can:
- Cause or worsen heart failure and severe swelling (edema) [21][22].
- Dramatically worsen high blood pressure while you are lying down [7][23].
- Cause your potassium levels to drop dangerously low (hypokalemia), which can affect your heart rhythm [24][25].
- Lead to higher rates of hospitalization compared to other blood pressure medications, especially in those with existing heart conditions [21].
Managing High Blood Pressure at Night
If your blood pressure while lying down remains very high (above 160–180 mmHg) even with your bed elevated, prioritize head-up positioning, medication timing, and a prescribed short-acting nighttime agent when appropriate [12][26].
Common questions in this guide
Why does my blood pressure drop when I stand but rise when I lie down?
What should I do when I feel dizzy or faint while standing?
How should I time midodrine or droxidopa?
Can salt and fluids help low blood pressure when I stand?
Can an abdominal binder help with blood pressure when I stand?
Why is fludrocortisone used cautiously in autonomic failure?
What should I do about very high blood pressure at bedtime?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my 'target' blood pressure when standing, and how high is too high for my lying-down pressure?
- 2.How should I adjust my dose of Midodrine or Droxidopa if I know I will be lying down for a procedure or a nap?
- 3.Given my heart health, is Fludrocortisone a safe option for me, or are the risks of fluid retention too high?
- 4.Can you show me how to properly fit an abdominal binder to ensure I’m getting the most benefit?
- 5.If my blood pressure is very high at bedtime, should we consider a short-acting medication to take only at night?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (27)
- 1
Management of Orthostatic Hypotension: A Review.
Moloney D, Youssef A, Okamoto LE
JAMA internal medicine 2026; doi:10.1001/jamainternmed.2026.0284.
PMID: 41941194 - 2
Orthostatic Hypotension: A Practical Approach to Investigation and Management.
Arnold AC, Raj SR
The Canadian journal of cardiology 2017; (33(12)):1725-1728 doi:10.1016/j.cjca.2017.05.007.
PMID: 28807522 - 3
Management of Orthostatic Hypotension.
Palma JA, Kaufmann H
Continuum (Minneapolis, Minn.) 2020; (26(1)):154-177 doi:10.1212/CON.0000000000000816.
PMID: 31996627 - 4
What do we really know about supine hypertension in patients with orthostatic hypotension.
Jordan J, Tank J, Heusser K, et al.
Current opinion in cardiology 2019; (34(4)):384-389 doi:10.1097/HCO.0000000000000633.
PMID: 31021876 - 5
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
Gibbons CH, Schmidt P, Biaggioni I, et al.
Journal of neurology 2017; (264(8)):1567-1582 doi:10.1007/s00415-016-8375-x.
PMID: 28050656 - 6
Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.
Eschlböck S, Wenning G, Fanciulli A
Journal of neural transmission (Vienna, Austria : 1996) 2017; (124(12)):1567-1605 doi:10.1007/s00702-017-1791-y.
PMID: 29058089 - 7
Blood pressure regulation in autonomic failure by dietary sodium, blood volume and posture.
Biaggioni I
Autonomic neuroscience : basic & clinical 2021; (236()):102891 doi:10.1016/j.autneu.2021.102891.
PMID: 34634681 - 8
Oral and intravenous hydration in the treatment of orthostatic hypotension and postural tachycardia syndrome.
Snapper H, Cheshire WP
Autonomic neuroscience : basic & clinical 2022; (238()):102951 doi:10.1016/j.autneu.2022.102951.
PMID: 35123367 - 9
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson's Disease and Other Synucleinopathies.
Palma JA, Thijs RD
Journal of Parkinson's disease 2024; (14(s1)):S81-S92 doi:10.3233/JPD-230173.
PMID: 37694308 - 10
Managed care approach to the treatment of neurogenic orthostatic hypotension.
Isaacson SH
The American journal of managed care 2015; (21(13 Suppl)):s258-68.
PMID: 26790110 - 11
The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging.
Newton JL, Frith J
Neurology 2018; (91(7)):e652-e656 doi:10.1212/WNL.0000000000005994.
PMID: 30006412 - 12
Supine hypertension: A state of the art.
Mantovani G, Marozzi I, Rafanelli M, et al.
Autonomic neuroscience : basic & clinical 2022; (241()):102988 doi:10.1016/j.autneu.2022.102988.
PMID: 35613491 - 13
Head-Up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson's Disease: A Case Report.
van der Stam AH, Shmuely S, de Vries NM, et al.
Case reports in neurology 2024; (16(1)):256-261 doi:10.1159/000541424.
PMID: 39474293 - 14
Tolerability and efficacy of full-body head-up tilt sleeping in Parkinson's disease and multiple system atrophy.
van der Stam AH, de Vries NM, Shmuely S, et al.
NPJ Parkinson's disease 2026; (12(1)).
PMID: 42143029 - 15
Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L, Espay AJ, Gelblum J, et al.
Postgraduate medicine 2015; (127(7)):702-15 doi:10.1080/00325481.2015.1050340.
PMID: 26012731 - 16
Midodrine-Induced Nightmares in the Treatment of Orthostatic Hypotension: A Case Report.
Tran L, Brodeur M
The Senior care pharmacist 2023; (38(12)):501-505 doi:10.4140/TCP.n.2023.501.
PMID: 38041226 - 17
Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach.
Amjad F, Polenchar B, Favit A
International journal of general medicine 2021; (14()):4485-4490 doi:10.2147/IJGM.S304012.
PMID: 34421309 - 18
Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Cheshire WP
Expert opinion on pharmacotherapy 2019; (20(2)):187-199 doi:10.1080/14656566.2018.1543404.
PMID: 30376728 - 19
Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
Chen JJ, Han Y, Tang J, et al.
The Annals of pharmacotherapy 2018; (52(12)):1182-1194 doi:10.1177/1060028018786954.
PMID: 29972032 - 20
Fludrocortisone for orthostatic hypotension.
Veazie S, Peterson K, Ansari Y, et al.
The Cochrane database of systematic reviews 2021; (5()):CD012868 doi:10.1002/14651858.CD012868.pub2.
PMID: 34000076 - 21
Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
Grijalva CG, Biaggioni I, Griffin MR, Shibao CA
Journal of the American Heart Association 2017; (6(10)) doi:10.1161/JAHA.117.006848.
PMID: 29025750 - 22
Heart failure and orthostatic hypotension.
Gorelik O, Feldman L, Cohen N
Heart failure reviews 2016; (21(5)):529-38 doi:10.1007/s10741-016-9541-z.
PMID: 26880254 - 23
Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR, Büchele F, Sommerauer M, et al.
European journal of neurology 2017; (24(4)):545-551 doi:10.1111/ene.13260.
PMID: 28224720 - 24
When Treatment Becomes the Trigger: Fludrocortisone-Associated Hypokalaemia in an Older Adult.
Phyo KC, Kyaw Z, Pyone ZM, et al.
Cureus 2026; (18(7)):e112116 doi:10.7759/cureus.112116.
PMID: 42558803 - 25
Trick or Treat? Licorice-Induced Hypokalemia: A Case Report.
Benge E, Shah P, Yamaguchi L, Josef V
Cureus 2020; (12(11)):e11656 doi:10.7759/cureus.11656.
PMID: 33391895 - 26
Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA, Mehta N, Távora-Mehta MZP, et al.
Arquivos brasileiros de cardiologia 2021; (116(4)):814-835 doi:10.36660/abc.20200420.
PMID: 33886735 - 27
Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension.
Jordan J, Fanciulli A, Tank J, et al.
Journal of hypertension 2019; (37(8)):1541-1546 doi:10.1097/HJH.0000000000002078.
PMID: 30882602
This page explains blood-pressure management in IPAN and pure autonomic failure for educational purposes and does not replace medical advice. Ask your clinician before changing salt, fluid, or medication use.
Get notified when new evidence is published on idiopathic peripheral autonomic neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.